SIDRE: Symptomatic Improvement of Dry Eye Study

Figures & data

Table 1 Patient demographics and baseline characteristics (n=14)

Gender, n (%)
Male	2 (14.2)
Female	12 (85.8)
Age, mean±SD (range)	44.86±3.08 (23–62)
Age distribution, years, n (%)
<30	1 (7.1)
31–45	7 (50.0)
45–60	5 (35.7)
>61	1 (7.1)

Abbreviation: SD, standard deviation.

Table 2 Time interval (days) between evaluation of pre- and posttreatment OSDI score

	Time interval (days)
Mean±SD	28.79±2.19
Range	25–34

Abbreviations: OSDI, Ocular Surface Disease Index; SD, standard deviation.

Table 3 Summary of pre- and posttreatment OSDI scores

	N	Mean	SD	Minimum	Maximum
Pretreatment scores	14	49.40	4.79	41.67	58.33
Posttreatment scores	14	42.26	3.69	37.50	47.92

Abbreviations: OSDI, Ocular Surface Disease Index; SD, standard deviation.

Table 4 Pre- and posttreatment scores by gender

Gender	n	Variable	Mean	SD	Minimum	Maximum
F	12	Age (years)	44.00	11.95	23.00	62.00
		Pretreatment score	49.31	4.89	41.67	58.33
		Posttreatment score	41.67	3.66	37.50	47.92
		Time interval between evaluation (days)	28.92	2.35	25.00	34.00
M	2	Age (years)	50.00	9.90	43.00	57.00
		Pretreatment score	50.00	5.90	45.83	54.17
		Posttreatment score	45.83	0.00	45.83	45.83
		Time interval between evaluation (days)	28.00	0.00	28.00	28.00

Abbreviations: SD, standard deviation; F, female; M, male.

Table 5 Scores by perception of therapy

Perception	n	Variable	Mean	SD	Minimum	Maximum
Neutral	7	Age (years)	46.43	13.20	23.00	58.00
		Pretreatment score	47.32	5.06	41.67	56.25
		Posttreatment score	41.07	3.34	37.50	45.83
		Time interval between evaluation (days)	28.86	1.35	27.00	31.00
Positive	7	Age (years)	43.29	10.42	32.00	62.00
		Pretreatment score	51.49	3.75	47.92	58.33
		Posttreatment score	43.45	3.89	39.58	47.92
		Time interval between evaluation (days)	28.71	2.93	25.00	34.00

Abbreviation: SD, standard deviation.